PLRX — Pliant Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $711.42m
- $227.23m
- $1.58m
- 55
- 12
- 29
- 23
Annual cashflow statement for Pliant Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.631 | -41.5 | -97.3 | -123 | -161 |
| Depreciation | |||||
| Non-Cash Items | 1.83 | 4.16 | 13.4 | 22.6 | 41.9 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.06 | -1.21 | 6.92 | 4.22 | 1.25 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -2.75 | -37.3 | -75.4 | -94.6 | -116 |
| Capital Expenditures | -0.964 | -1.53 | -1.95 | -1.76 | -0.921 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -17 | -209 | 75.7 | -148 | -126 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -17.9 | -211 | 73.7 | -150 | -127 |
| Financing Cash Flow Items | -2.58 | 0 | -0.457 | -0.557 | -0.847 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 45.5 | 213 | 2.53 | 227 | 274 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 24.9 | -34.9 | 0.783 | -18 | 31 |